Singular Health Group is set to pocket up to $850,000 in strategic investment from the venture arm of the recently-appointed US master distributor Charlie Golf One Solutions (CG1), which will market the company’s 3D medical imaging software in the United States.
The company confirmed today it has received a binding commitment to raise between $500,000 and $850,000 through the issue of fully-paid ordinary shares to CG1 Ventures as part of a strategic investment at a 41 per cent premium to its previous ASX closing price of 3.9 cents.
The stock rose to as high as 5.1c in today’s intraday trading.
Last month, Singular appointed CG1, a South Florida-based information technology firm owned and run by veterans and service-disabled veterans, to take on the US distribution of its “3Dicom” medical imaging software.
We are very pleased to welcome CG1 Ventures’ strategic investment in…